62 results on '"Monto, Alexander"'
Search Results
2. Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease
3. Telehepatology Use and Satisfaction Among Vulnerable Cirrhosis Patients Across Three Healthcare Systems in the Coronavirus Disease Pandemic Era
4. Portal Vein Thrombosis After Transarterial Embolization for Hepatocellular Carcinoma
5. Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project
6. Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
7. Tu1267: TELEMEDICINE DURING COVID-19 PANDEMIC IS AN ACCEPTABLE MODALITY FOR LIVER CARE DELIVERY IN VULNERABLE POPULATIONS WITH FATTY LIVER DISEASE
8. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
9. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms
10. Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders
11. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US Veterans
12. Screening for Hepatocellular Carcinoma to Improve Cancer-Related Mortality: Looking Behind When We Should Be Looking Ahead
13. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success
14. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma
15. Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities
16. Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement
17. Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
18. Tu1687 Sofosbuvir Plus Ribavirin for 12 Weeks in Genotype 2 HCV Compensated Cirrhotic Patients; A Comparative Analysis of VALOR-HCV SVR Data to Registration Trials and Real World Cohorts
19. Examining Hepatitis C Virus Treatment Preference Heterogeneity Using Segmentation Analysis
20. Genetic Variation in theIL-6andHLA-DQB1Genes Is Associated with Spontaneous Clearance of Hepatitis C Virus Infection
21. Variation in Treatment Priorities for Chronic Hepatitis C: A Latent Class Analysis
22. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma
23. Contrast-Enhanced CT Quantification of the Hepatic Fractional Extracellular Space: Correlation With Diffuse Liver Disease Severity
24. Tu1058 Surgical Resection of Hepatocellular Carcinoma May Confer Survival Advantage Over Radiofrequency Ablation or Locoregional Therapy in Barcelona Clinic Liver Cancer (BCLC) Stage B Patients
25. Nonresponse to Interferon-α Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
26. Impaired Lymphocyte Reactivity Measured by Immune Function Testing in Untransplanted Patients with Cirrhosis
27. Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment
28. Differential Cognitive Impairment in HCV Coinfected Men With Controlled HIV Compared to HCV Monoinfection
29. IsIL28Bgenotype associated with more than one aspect of viral clearance?
30. Su2061 Hepatocellular Carcinoma With a Plan for Surgical Resection is Associated With Improved Survival Compared to a Plan for Liver Transplantation
31. 938 Does Nonresponse/Relapse to Interferon-Based Therapy Affect Cirrhosis Development and Survival?
32. Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
33. Multi-center evaluation of the Abbott RealTime HCV Assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C
34. Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
35. Progression of Biopsy-Measured Liver Fibrosis in Untreated Patients with Hepatitis C Infection: Non-Markov Multistate Model Analysis
36. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid
37. Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center
38. Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop
39. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C
40. Non-Markov Multistate Modeling Using Time-Varying Covariates, with Application to Progression of Liver Fibrosis due to Hepatitis C Following Liver Transplant
41. Association of Hepatitis C Virus Seropositivity With Inflammatory Markers and Heart Failure in Persons With Coronary Heart Disease: Data From the Heart and Soul Study
42. Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy
43. Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival
44. Efficacy and Safety of Peginterferon Alfa-2a/Ribavirin in Methadone Maintenance Patients: Randomized Comparison of Direct Observed Therapy and Self-Administration
45. Corrigendum to “A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus” [Drug Alcohol Depend. 93(1–2) (2008) 148–154]
46. 121. HCV infection induces monocyte secretion of proinflammatory cytokines that are neurotoxic
47. Liver Disease in Injection Drug Users with Hepatitis C, With and Without HIV Coinfection
48. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus
49. Contributions to Hepatic Fibrosis in HIV-HCV Coinfected and HCV Monoinfected Patients
50. Identification of Two Gene Variants Associated With Risk of Advanced Fibrosis in Patients With Chronic Hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.